多囊卵巢综合征的现行诊断指南。
Current Guidelines for Diagnosing PCOS.
作者信息
Christ Jacob P, Cedars Marcelle I
机构信息
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA.
出版信息
Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women. Much of the confusion surrounding PCOS diagnosis stems from the broad heterogeneity of symptomology experienced by women with PCOS. The diverse features of the syndrome have led to a number of diagnostic criteria over the years. This manuscript describes each of the current composite criteria and individually breaks down each component. The importance of accurate diagnosis for both clinical care and research is emphasized.
摘要
多囊卵巢综合征（PCOS）是育龄女性最常见的内分泌疾病。围绕PCOS诊断的许多困惑源于患有PCOS的女性症状学的广泛异质性。多年来，该综合征的多样特征导致了多种诊断标准。本文描述了当前的每一种综合标准，并分别剖析了每个组成部分。强调了准确诊断对临床护理和研究的重要性。
相似文献
1
Current Guidelines for Diagnosing PCOS.多囊卵巢综合征的现行诊断指南。
Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113.
2
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.根据鹿特丹标准与包括抗苗勒管激素在内的修订标准，正常人群中多囊卵巢综合征的患病率。
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
3
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征的患病率及表型特征：一项系统评价与荟萃分析
Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22.
4
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.临床内分泌学争议：多囊卵巢综合征的诊断：鹿特丹标准尚不成熟。
J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17.
5
Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.转诊至三级生殖医学中心的老年女性多囊卵巢综合征的患病率、临床特征及生殖结局
Arch Gynecol Obstet. 2018 Apr;297(4):1037-1042. doi: 10.1007/s00404-017-4642-z. Epub 2017 Dec 30.
6
High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?1型糖尿病青少年中多囊卵巢综合征的高患病率：根据美国国立卫生研究院（NIH）和鹿特丹标准是否存在差异？
Horm Res Paediatr. 2017;87(5):333-341. doi: 10.1159/000471805. Epub 2017 Apr 24.
7
8
Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study.澳大利亚临床医生对多囊卵巢综合征诊断的看法：一项定性研究。
Hum Reprod. 2020 Mar 27;35(3):660-668. doi: 10.1093/humrep/deaa005.
9
Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.采用基于社区的参考范围，通过公认的诊断标准评估多囊卵巢综合征的流行情况：一项横断面研究。
Hum Reprod. 2021 May 17;36(6):1611-1620. doi: 10.1093/humrep/deab069.
10
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.临床内分泌学争议：多囊卵巢综合征的诊断：为鹿特丹标准辩护。
J Clin Endocrinol Metab. 2006 Mar;91(3):786-9. doi: 10.1210/jc.2005-2501. Epub 2006 Jan 17.
引用本文的文献
1
Polycystic Ovary Syndrome and the Effects of a Ketogenic Diet: A Scoping Review.多囊卵巢综合征与生酮饮食的影响：一项范围综述
Nutrients. 2025 Sep 7;17(17):2893. doi: 10.3390/nu17172893.
2
Molecular Insights into Elevated Autoantibodies in Polycystic Ovary Syndrome: Mechanisms and Clinical Implications.多囊卵巢综合征中自身抗体升高的分子机制及临床意义的研究进展
Int J Mol Sci. 2025 Aug 23;26(17):8192. doi: 10.3390/ijms26178192.
3
Temporal Trends and Machine Learning-Based Risk Prediction of Female Infertility: A Cross-Cohort Analysis Using NHANES Data (2015-2023).女性不孕症的时间趋势及基于机器学习的风险预测：使用美国国家健康与营养检查调查（NHANES）数据（2015 - 2023年）的跨队列分析
Diagnostics (Basel). 2025 Sep 5;15(17):2250. doi: 10.3390/diagnostics15172250.
4
Hypertension and Polycystic Ovary Syndrome Among Women in a Nationwide Electronic Health Records Dataset in the United States.美国全国电子健康记录数据集中女性的高血压与多囊卵巢综合征
Matern Child Health J. 2025 Sep 1. doi: 10.1007/s10995-025-04155-x.
5
Knowledge, Attitude, and Practice of Polycystic Ovarian Syndrome Diagnosis among Health Care Providers in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴医疗服务提供者对多囊卵巢综合征诊断的知识、态度和实践
BMC Womens Health. 2025 Aug 29;25(1):414. doi: 10.1186/s12905-025-03948-0.
6
Obesity as a Part of Polycysric Ovary Syndrome (PCOS)-A Review of Pathophysiology and Comprehensive Therapeutic Strategies.肥胖作为多囊卵巢综合征（PCOS）的一部分——病理生理学及综合治疗策略综述
J Clin Med. 2025 Aug 9;14(16):5642. doi: 10.3390/jcm14165642.
7
Multifactorial Refractory Acne in Women: Insights from a Case Series Involving Hormonal-, Metabolic-, and Corticosteroid-Related Triggers.女性多因素难治性痤疮：来自一个涉及激素、代谢和皮质类固醇相关触发因素的病例系列的见解
Life (Basel). 2025 Jul 28;15(8):1196. doi: 10.3390/life15081196.
8
Visceral Adiposity Index in Relation to Rotterdam Phenotypes of Polycystic Ovary Syndrome.内脏脂肪指数与多囊卵巢综合征的鹿特丹分型的关系
Biomedicines. 2025 Aug 16;13(8):1997. doi: 10.3390/biomedicines13081997.
9
FIB-4 Score as a Predictor of Eligibility for Elastography Exam in Patients with Polycystic Ovary Syndrome.FIB-4评分作为多囊卵巢综合征患者弹性成像检查适用性的预测指标。
Biomedicines. 2025 Aug 1;13(8):1878. doi: 10.3390/biomedicines13081878.
10
Comparative advantage and efficacy of natural products for polycystic ovary syndrome.天然产物治疗多囊卵巢综合征的比较优势与疗效
J Ovarian Res. 2025 Aug 9;18(1):178. doi: 10.1186/s13048-025-01756-6.
本文引用的文献
1
Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome.多囊卵巢综合征患者的 3 种不同 AMH 检测方法与 AMH 水平和卵泡计数的比较。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3714-e3722. doi: 10.1210/clinem/dgac370.
2
Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study.个体多囊卵巢综合征表型特征随时间的变化：一项长期随访研究。
Fertil Steril. 2022 May;117(5):1059-1066. doi: 10.1016/j.fertnstert.2022.01.014. Epub 2022 Feb 24.
3
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.多囊卵巢综合征在美国的医疗保健相关经济负担：与妊娠相关的和长期的健康后果。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):575-585. doi: 10.1210/clinem/dgab613.
4
Age-group-specific reference intervals for anti-Müllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population.按年龄组划分的韩国人群抗苗勒管激素参考区间及其在多囊卵巢综合征诊断中的性能。
J Clin Lab Anal. 2021 Jul;35(7):e23861. doi: 10.1002/jcla.23861. Epub 2021 Jun 7.
5
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review.多囊卵巢综合征的患病率：一项简要的系统评价。
J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28.
6
Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis.多囊卵巢综合征女性中寻常痤疮的患病率：系统评价和荟萃分析。
Gynecol Endocrinol. 2021 May;37(5):392-405. doi: 10.1080/09513590.2020.1859474. Epub 2020 Dec 23.
7
Adolescent polycystic ovary syndrome according to the international evidence-based guideline.青少年多囊卵巢综合征的国际循证指南。
BMC Med. 2020 Mar 24;18(1):72. doi: 10.1186/s12916-020-01516-x.
8
Age-specific reference ranges of serum anti-müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study.血清抗缪勒管激素在健康女性中的年龄特异性参考范围及其在多囊卵巢综合征诊断中的应用：一项人群研究。
BJOG. 2020 May;127(6):720-728. doi: 10.1111/1471-0528.16147. Epub 2020 Feb 25.
9
Female Androgenetic Alopecia: An Update on Diagnosis and Management.女性雄激素性脱发：诊断与治疗的最新进展。
Am J Clin Dermatol. 2020 Feb;21(1):69-84. doi: 10.1007/s40257-019-00479-x.
10
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles.超过60万个月经周期的真实世界月经周期特征。
NPJ Digit Med. 2019 Aug 27;2:83. doi: 10.1038/s41746-019-0152-7. eCollection 2019.
Zotero 插件